Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Intermediate and high-risk clonal hematopoiesis in germline predisposition families

Sandra Novoa Jáuregui, Sara Torres-Esquius, Maria Gabarrós Subirà, Pamela Acha, Francisco Beas, Ana Maria Garrido, Marc Bosch-Schips, Claudia Pellin Jou, Adriana Oños, Sílvia Saumell Tutusaus, Ana Perez Gonzalez, Adoracion Blanco, David Valcarcel, Francesc Bosch Albareda, Andres Jerez, Maria Julia Montoro

Blood (2025) 146 (Supplement 1): 2058.

https://doi.org/10.1182/blood-2025-2058

Published: 2025

Journal Articles

Single-cell transcriptomics reveal long non-coding RNA dysregulation in PPP1R15B-EIF2A axis impairing erythroid maturation in myelodysplastic syndromes

Francisco Beas, Enrique Goñi, Aintzane Diaz-Mazkiaran, Teresa Ezponda, Ana Alfonso-Pierola, Andres Jerez, Felipe Prosper, David Valcarcel, Mikel Hernáez Arrazola

Blood (2025) 146 (Supplement 1): 2056.

https://doi.org/10.1182/blood-2025-2056

Published: 2025

Journal Articles

Bone marrow alterations and clonal hematopoiesis in germline ETV6 mutation carriers without hematologic malignancy

Sara Torres-Esquius, Maria Gabarros-Subira, Carmelo Gurnari, Carlos Bravo-Perez, Guillermo Ramil López, Raquel De Paz Arias, Alejandro Sanz, Maria Muñoz Martinez, Francisco Beas, Sandra Novoa Jáuregui, Marta Pratcorona Canela, Silvia Saumell, Maria Teresa Voso, Jaroslaw Maciejewski, Pamela Acha, David Valcarcel, Andres Jerez, Maria Julia Montoro

Blood (2025) 146 (Supplement 1): 4997.

https://doi.org/10.1182/blood-2025-4997

Published: 2025

Journal Articles

Proliferation of mature plasmacytoid dendritic cells in RUNX1-mutated Acute Myeloid Leukemia

Blood (2025) 146 (Supplement 1): 7004.

https://doi.org/10.1182/blood-2025-7004

Published: 2025

Journal Articles

Beyond TP53: Molecular IPSS-genes multihit status revisited

Blood (2025) 146 (Supplement 1): 2090.

https://doi.org/10.1182/blood-2025-2090

Published: 2025

Journal Articles

EZH2 molecular alterations drive micromegakaryocyte expansion in MDS defining a specific high-risk group

Blood (2025) 146 (Supplement 1): 2084.

https://doi.org/10.1182/blood-2025-2084

Published: 2025

Journal Articles

Lineage-specific distribution of clonal hematopoiesis of indeterminate potential across mature hematopoietic subpopulations in cancer patients

Blood (2025) 146 (Supplement 1): 4949.

https://doi.org/10.1182/blood-2025-4949

Published: 2025

Journal Articles

Incidence and molecular underpinnings of donor-cell derived neoplasm among spanish transplantation centers

Blood (2025) 146 (Supplement 1): 4275.

https://doi.org/10.1182/blood-2025-4275

Published: 2025

Journal Articles

Impact of extranodal involvement on bispecific antibody (BsAb) outcomes in patients with large B-cell lymphoma (LBCL)

Blood (2025) 146 (Supplement 1): 1962.

https://doi.org/10.1182/blood-2025-1962

Published: 2025

Journal Articles

Ultra-Deep Sequencing of TP53 in Multiple Myeloma: Double-Hit Prevalence and Clinical Phenotype

Blood (2024) 144 (Supplement 1): 1935.

https://doi.org/10.1182/blood-2024-208559

Published: 2024

Journal Articles

Evaluation of the Prognostic Impact of STAG2 in the Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

Francisco Beas, Sandra Novoa Jáuregui, María Gabarrós-Subirà, María Eugenia Rivero, Clàudia Pellín Jou, Pamela Acha, Alba Puyuelo, Silvia Saumell, Ana María Garrido, Félix López Cadenas, Ana Pérez, Carlos Eduardo Chávez, Adoracion Blanco, Laura Gallur, Gloria Hidalgo-Gómez, Francesc Bosch, Maria Julia Montoro, David Valcarcel, Andres Jerez

Blood (2024) 144 (Supplement 1): 6742.

https://doi.org/10.1182/blood-2024-206758

Published: 2024

Journal Articles

Prevalence, Dynamics and Clinical Significance of Clonal Hematopoiesis of Indeterminate Potential (CHIP) in Newly Diagnosed Cancer Patients

Blood (2023) 142 (Supplement 1): 5593.

https://doi.org/10.1182/blood-2023-189503

Published: 2023

Journal Articles

Germline Predisposition in Myeloid Neoplasms Aged ≥50: A Novel Approach for Allogeneic Stem Cell -Transplantation Decision-Making

Blood (2023) 142 (Supplement 1): 5663.

https://doi.org/10.1182/blood-2023-179234

Published: 2023

Journal Articles

Clinical Impact of the New Bone Marrow Blasts Cutoff Defined By the International Classification Consortium (ICC) in Myeloid Neoplasms with Mutated TP53 gene

Blood (2023) 142 (Supplement 1): 3235.

https://doi.org/10.1182/blood-2023-181698

Published: 2023

Journal Articles

Apixaban Vs Vitamin K Antagonist As Anticoagulant Therapy in Patients with End-Stage Kidney Disease on Hemodialysis and with Atrial Fibrillation

Sofia Muzio, Gonzalo Artaza, Olga Benitez Hidalgo, Vicente Cortina, Desiree Campoy, Francisco Beas, Marc Bosch, Marina Serra, Francesc Bosch, Pável E Olivera

Blood (2023) 142 (Supplement 1): 4019.

https://doi.org/10.1182/blood-2023-190604

Published: 2023

Journal Articles

Results of Treatment Approaches in Myeloid Neoplasms According to TP53 Allelic Status (Multi-hit vs Monoallelic), a Real World Analysis

Maria Sola, Francisco Beas, Laura Palomo, Mar Tormo, Ana Riera, Nicolas Díaz Varela, Teresa Bernal, Sara García, Concepción Fernández, Nieves Garcia-Gisbert, Félix López Cadenas, Barbara Tazon, Adoracion Blanco, Sara Garrido Paniagua, Ana Pérez González, Andres Jerez, Julia Montoro, Olga Salamero, David Valcarcel

Blood (2023) 142 (Supplement 1): 3227.

https://doi.org/10.1182/blood-2023-187101

Published: 2023

Journal Articles

PET Radiomic Features Are Predictive of Outcomes after Chimeric Antigen Receptor T-Cell Therapy in Patients with Large B-Cell Lymphoma

Pere Barba, Marta Ligero, Cecilia Carpio, Maria Balaguer, Víctor Navarro Garcés, Sabela Bobillo, Francisco Beas, Pau Abrisqueta, Roser Sala, Francesc Bosch, Gloria Iacoboni, Marc Simo, Raquel Perez-Lopez

Blood (2022) 140 (Supplement 1): 3783–3784.

https://doi.org/10.1182/blood-2022-167172

Published: 2022

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Intermediate and high-risk clonal hematopoiesis in germline predisposition families

Single-cell transcriptomics reveal long non-coding RNA dysregulation in PPP1R15B-EIF2A axis impairing erythroid maturation in myelodysplastic syndromes

Bone marrow alterations and clonal hematopoiesis in germline ETV6 mutation carriers without hematologic malignancy

Proliferation of mature plasmacytoid dendritic cells in RUNX1-mutated Acute Myeloid Leukemia

Beyond TP53: Molecular IPSS-genes multihit status revisited

EZH2 molecular alterations drive micromegakaryocyte expansion in MDS defining a specific high-risk group

Lineage-specific distribution of clonal hematopoiesis of indeterminate potential across mature hematopoietic subpopulations in cancer patients

Incidence and molecular underpinnings of donor-cell derived neoplasm among spanish transplantation centers

Impact of extranodal involvement on bispecific antibody (BsAb) outcomes in patients with large B-cell lymphoma (LBCL)

Ultra-Deep Sequencing of TP53 in Multiple Myeloma: Double-Hit Prevalence and Clinical Phenotype

Evaluation of the Prognostic Impact of STAG2 in the Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

Prevalence, Dynamics and Clinical Significance of Clonal Hematopoiesis of Indeterminate Potential (CHIP) in Newly Diagnosed Cancer Patients

Germline Predisposition in Myeloid Neoplasms Aged ≥50: A Novel Approach for Allogeneic Stem Cell -Transplantation Decision-Making

Clinical Impact of the New Bone Marrow Blasts Cutoff Defined By the International Classification Consortium (ICC) in Myeloid Neoplasms with Mutated TP53 gene

Apixaban Vs Vitamin K Antagonist As Anticoagulant Therapy in Patients with End-Stage Kidney Disease on Hemodialysis and with Atrial Fibrillation

Results of Treatment Approaches in Myeloid Neoplasms According to TP53 Allelic Status (Multi-hit vs Monoallelic), a Real World Analysis

PET Radiomic Features Are Predictive of Outcomes after Chimeric Antigen Receptor T-Cell Therapy in Patients with Large B-Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only